Marylena Fishkin, in Glen Burnie, MD - Physical Medicine & Rehabilitation

Marylena Fishkin, is a Physical Medicine & Rehabilitation physician based in Glen Burnie, Maryland. Marylena Fishkin is licensed to practice in Maryland (license number A5763) and her current practice location is 368 Cork Rd, Glen Burnie, Maryland. She can be reached at her office (for appointments etc.) via phone at (443) 635-9194.

NPI number for Marylena Fishkin is 1336913862 and her current mailing address is 368 Cork Rd, Glen Burnie, Maryland. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1336913862.

Contact Information

	Marylena Fishkin,
	368 Cork Rd, Glen Burnie, MD 21060-8229
	(443) 635-9194
	Not Available

Physician's Profile

Full Name	Marylena Fishkin
Gender	Female
Speciality	Physical Medicine & Rehabilitation
Location	368 Cork Rd, Glen Burnie, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1336913862
Provider Enumeration Date: 11/15/2023
Last Update Date: 11/15/2023

Medical Identifiers

Medical identifiers for Marylena Fishkin such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1336913862	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208100000X	Physical Medicine & Rehabilitation	A5763 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Marylena Fishkin is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Marylena Fishkin, 368 Cork Rd, Glen Burnie, MD 21060-8229 Ph: (443) 635-9194	Marylena Fishkin, 368 Cork Rd, Glen Burnie, MD 21060-8229 Ph: (443) 635-9194

News Archive

WSU researcher receives $418,000 NINDS grant to study spinal muscular atrophy

Graham Parker, Ph.D., assistant professor of research in the Department of Pediatrics at Wayne State University's School of Medicine, was awarded $418,000 from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health to study how a particular gene might be involved in the progression of spinal muscular atrophy (SMA) - the number one genetic killer of children younger than 2 years old.

Nanobio hybrids for brain cancer therapy

In an advance toward better treatments for the most serious form of brain cancer, scientists in Illinois are reporting development of the first nanoparticles that seek out and destroy brain cancer cells without damaging nearby healthy cells. The study is scheduled for the Sept. 9 issue of ACS' Nano Letters, a monthly journal.

Structural analogs of triterpenoids show strong inhibitory activity against coronaviruses

In a recent study published in the journal Pathogens, researchers carried out a molecular docking study for 17 structural analogs prepared from natural maslinic and oleanolic acids and screened them against SARS-CoV-2 main protease. They also experimentally validated the data by determining the half-maximal cytotoxic and inhibitory concentrations of each of the 17 compounds. The researchers investigated whether the compound with antiviral activity affected viral adsorption, replication, or viricidal effect using a plaque infectivity reduction assay.

NCI acquires AdvanceMed

NCI, Inc., a leading provider of information technology (IT), engineering, logistics, and professional services and solutions to U.S. Federal Government agencies, announced today that it has acquired the outstanding capital stock of AdvanceMed Corporation, an affiliate of CSC.

FDA grants Biovest's BiovaxID vaccine Orphan Drug Designation for mantle cell lymphoma

Biovest International, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to BiovaxID®, Biovest's personalized cancer vaccine, for a second lymphoma indication: mantle cell lymphoma. Mantle cell lymphoma is an aggressive and lethal B-cell blood cancer for which there is no current consensus standard-of-care.

Physical Medicine & Rehabilitation Doctors in Glen Burnie, MD

Sydney Cope, DPT Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1911 Crain Hwy S, Glen Burnie, MD 21061 Phone: 443-960-7442
Susan Zimmerman, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 331 Oak Manor Dr, Suite 102, Glen Burnie, MD 21061 Phone: 410-266-2711 Fax: 410-269-1149
Sarah M White, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1600 S Crain Highway, Suite 401, Glen Burnie, MD 21061 Phone: 410-768-5050 Fax: 443-782-0713

Marylena Fishkin, - Physical Medicine & Rehabilitation in Glen Burnie, MD